ArticleMolecular oncology2023

Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group.

Nour-El-Houda Mourksi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.